Fast-growing biotech startup targets 2020 for Series A funding, start of clinical trials

St. Louis Business Journal

Nov 8, 2019

The St. Louis-based startup, Wugen, is developing "off the shelf" medicine to treat various cancers. The company was created from technology licensed from Washington University res…